|Tuesday, October 1, 2019|
|05:30 PM - 06:30 PM British Summer Time|
|12:30 PM - 01:30 PM Eastern Daylight Time|
|09:30 AM - 10:30 AM Pacific Daylight Time|
Commissioners, regulators, and payers are making increasing evidential demands to show value in relation to the pricing and reimbursement of innovative medicines. Although the mechanisms differ, these demands stem from the same driver—the perceived need to control healthcare product budgets. Join our London lawyer Paul Ranson for a one-hour webinar to discuss the issues and challenges arising from the growing need for producers to demonstrate value and share risk.